Magnetic nanoparticles and thermally responsive polymer for targeted hyperthermia and sustained anti-cancer drug delivery

Advances in Experimental Medicine and Biology

Volumn 765, Issue , 2013, Pages 315-321

  Wang, Sarah Y ^a,b   Liu, Michelle C ^a,b   Kang, Kyung A ^b  

^a DUPONT COMPANY   (United States)

^b University of Louisville   (United States)

Author keywords

Anti cancer drug delivery; Nanoparticles

Indexed keywords

IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLE; POLOXAMER; POLYMER; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BODY TEMPERATURE; CANCER THERAPY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DRUG DELIVERY SYSTEM; GELATION; HEATING; HYPERTHERMIC THERAPY; PHASE TRANSITION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; ROOM TEMPERATURE; SUSTAINED DRUG RELEASE; TEMPERATURE SENSITIVITY; AQUEOUS SOLUTION; CONTROLLED STUDY; DRUG RELEASE; ELECTROMAGNETISM; HYPERTHERMIA;

EID: 84867527166     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4989-8_44     Document Type: Conference Paper

References (18)

1. Miyazaki S, Ohkawa Y, Takada M et al (1992) Anti-tumor effect of Pluronic F-127 containing Mitomycin C on Saroma 180 ascites tumor. Chem Pharm Bull 40:2224-2226
2. Hate fi A, Amsden B (2002) Review: biodegradable injectable in situ forming drug delivery systems. Release 80:9-28
3. Escobar-Chávez JJ, López-Cervantes M, Naïk A et al (2006) Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Sci 9:339-358
4. Rapoport N (2007) Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci 32:962-990
5. Jeong B, Kim SW, Bae YH (2002) Thermosensitive sol-gel reversible hydrogels. Adv Drug Del Rev 54:37-51
6. Cabana A, Ait-Kadi A, Juhász J (1997) Study of the gelation process of polyethylene oxidepolypropylene oxide-polyethylene oxide copolymer (Poloxamer 407) aqueous solutions. J Colloid Interface Sci 190:307-312
7. Chung HJ, Go DH, Bae JW et al (2005) Synthesis and characterization of Pluronic® grafted chitosan copolymer as a novel injectable biomaterial. Curr Appl Phys 5:485-488
8. Lenaerts V, Triqueneaux C, Quartern M et al (1987) Temperature-dependent rheological behavior of Pluronic F-127 aqueous solutions. Int J Pharm 39:121-127
9. Anderson BC, Pandit NK, Mallapragada SK (2001) Understanding drug release from poly (ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. J Control Release 70:157-167
10. Jeong B, Bae YH, Kim SW (2000) Drug release from biodegradable injectable thermosensitive hydrogel of PEF-PLGA-PEG triblock copolymers. J Control Release 63:155-163
11. Zhang L, Parsons DL, Navarre C et al (2002) Development and in-vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur. J Control Release 85:73-81
12. Moore T, Croy S, Mallapragada S et al (2000) Experimental investigation and mathematical modeling of Pluronic® F127 gel dissolution: drug release in stirred systems. J Control Release 67:191-202
13. Kaowumpai W, Koolpiruck D, Viravaidya K (2007) Development of a 3D mathematical model for a doxorubicin controlled release system using pluronic gel for breast cancer treatment. Proceedings of the World Academy of Science, Engineering and Technology December: 287-292
14. Xu X, Lee P (1993) Programmable drug delivery from an erodible association polymer system. Pharm Res 10:1144-1152
15. Hong YJ, Lee HY, Kim J (2009) Preparations and temperature-dependent release properties of Pluronic F-127 containing microcapsules prepared by a double emulsion technique. J Ind Eng Chem 15:758-762
16. El-Kamel AH (2002) In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system fortimolol maleate. Int J Pharm 241:47-55
17. Sanapala KK, Hewparakrama K, Kang KA (2009) Effect of AEM energy applicator con fi guration of magnetic nanoparticles mediated hyperthermia for breast cancer. Adv Exp Med Biol Oxygen Trans Tissue 32:143-147
18. Jin H, Kang KA (2007) Application of novel metal nanoparticles as optical/thermal agents in optical mammography and hyperthermia treatment for breast cancer. Adv Exp Med Biol Oxygen Trans Tissue 28:45-52